Maravai Lifesciences Holdings (MRVI) Enterprise Value (2020 - 2026)

Maravai Lifesciences Holdings' Enterprise Value history runs 7 years deep, the most recent figure standing at -$8.4 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 84.83% year-over-year to -$8.4 million; the TTM figure through Mar 2026 stood at -$8.4 million (up 84.83% YoY), while the FY2025 annual figure was -$56.6 million, up 21.29% from the prior year.
• Enterprise Value was -$8.4 million for Q1 2026 at Maravai Lifesciences Holdings, up from -$56.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $379.1 million in Q1 2023 to a low of -$310.4 million in Q3 2024.
• Historically, Enterprise Value has averaged -$37.8 million across 5 years, with a median of -$67.8 million in 2025.
• Biggest YoY gain for Enterprise Value was 172.6% in 2022; the steepest drop was 218.38% in 2022.
• A 5-year view of Enterprise Value shows it stood at -$272.1 million in 2022, then climbed by 25.83% to -$201.8 million in 2023, then soared by 64.4% to -$71.9 million in 2024, then advanced by 21.29% to -$56.6 million in 2025, then jumped by 85.14% to -$8.4 million in 2026.
• The last three Enterprise Value figures came in at -$8.4 million (Q1 2026), -$56.6 million (Q4 2025), and -$57.2 million (Q3 2025), per Business Quant data.